Y, S., P, V., J, B., A, P., V, S., HL, G., . . . F, L. (2022). Residual risk of mother-to-child transmission of hepatitis B virus infection despite timely birth-dose vaccination in Cameroon (ANRS 12303): A single-centre, longitudinal observational study. The Lancet. Global health, 10(4), e521. https://doi.org/10.1016/S2214-109X(22)00026-2
Chicago Style (17th ed.) CitationY, Shimakawa, et al. "Residual Risk of Mother-to-child Transmission of Hepatitis B Virus Infection Despite Timely Birth-dose Vaccination in Cameroon (ANRS 12303): A Single-centre, Longitudinal Observational Study." The Lancet. Global Health 10, no. 4 (2022): e521. https://doi.org/10.1016/S2214-109X(22)00026-2.
MLA (9th ed.) CitationY, Shimakawa, et al. "Residual Risk of Mother-to-child Transmission of Hepatitis B Virus Infection Despite Timely Birth-dose Vaccination in Cameroon (ANRS 12303): A Single-centre, Longitudinal Observational Study." The Lancet. Global Health, vol. 10, no. 4, 2022, p. e521, https://doi.org/10.1016/S2214-109X(22)00026-2.